Clustered Mendelian Randomization analyses identifies distinct and opposing pathways in the causal association between insulin-like growth factor-1 and type 2 diabetes mellitus
Wenyi WangiD, Ephrem Baraki Tesfay, Jan Bert van KlinkeniD, Ko Willems van DijkiD, Andrzej BartkeiD, Diana van HeemstiD, Raymond NoordamiD
Abstract
Aims/hypothesisThere is inconsistent evidence for the causal role of serum insulin-like growth factor-1 (IGF-1) concentration in the pathogenesis of type 2 diabetes. Here, we investigated the association between IGF-1 and type 2 diabetes using a combination of multivariable-adjusted and (clustered) Mendelian Randomization (MR) analyses in the UK Biobank. MethodsWe conducted Cox proportional hazard analyses in 451,232 European-ancestry individuals of the UK Biobank (55.3% women, mean age at recruitment 56.6 years), among which 13,247 individuals developed type 2 diabetes during up to 12 years of follow-up. In addition, we conducted two-sample MR analyses based on independent SNPs associated with IGF-1. Given the heterogeneity between the causal estimates of individual instruments (P-value for Q statistic=4.03e-145), we also conducted clustered MR analyses. Biological pathway analyses of the identified clusters were performed by overrepresentation analyses. ResultsIn the Cox proportional hazard models, with IGF-1 concentrations stratified in quintiles, we observed that participants in the lowest quintile had the highest relative risk of type 2 diabetes (HR: 1.31; CI: 1.23-1.39). In contrast, in the two-sample MR analyses, higher genetically-influenced IGF-1 was associated with a higher risk of type 2 diabetes. Based on the heterogeneous distribution of causal effect estimates, six clusters associated either with a lower or a higher risk of type 2 diabetes were identified. The main clusters in which a higher IGF-1 was associated with a lower risk of type 2 diabetes consisted of instruments mapping to genes in the growth-hormone signaling pathway, whereas the main clusters in which a higher IGF-1 was associated with a higher risk of type 2 diabetes consisted of instruments mapping to genes in pathways related to amino acid metabolism and genomic integrity. ConclusionThe IGF-1 associated SNPs used as genetic instruments in MR analyses showed a heterogeneous distribution of causal effect estimates on the risk of type 2 diabetes. This was likely explained by differences in the underlying molecular pathways that increase IGF-1 concentration and differentially mediate the effects of IGF-1 on type 2 diabetes.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 14
- FWCI
- 2.11
- Field percentile
- top 13%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Relationship between branched chain amino acids and type 2 diabetes: a bidirectional Mendelian Randomization study
Jonathan D. Mosley, Mingjian Shi, … Jane F. Ferguson·medRxiv·May 23, 2023
- Evaluation of the causal associations between brain imaging-derived phenotypes and type 2 diabetes: a bidirectional Mendelian randomization study
Shan‐Shan Dong, Ke Yu, … Tie‐Lin Yang·medRxiv·Dec 16, 2022
- The putative causal effect of type 2 diabetes in risk of cataract: a Mendelian randomization study in East Asian
Haoyang Zhang, Xuehao Xiu, … Huiying Zhao·International Journal of EpidemiologyPeer-reviewed·Aug 3, 2021
- Inference of causal and pleiotropic effects with multiple weak genetic instruments: application to effect of adiponectin on type 2 diabetes
Paul McKeigue, Andrii Iakovliev, … Helen Martina Colhoun·medRxiv·Dec 15, 2023
- Shared genetic contribution to type 1 and type 2 diabetes risk
Anthony Aylward, Joshua Chiou, … Kyle J. Gaulton·bioRxiv·May 7, 2018
- Insulin-like growth factor-1 (IGF-1), insulin-like growth factor-binding protein-3 (IGFBP-3) and breast cancer risk: observational and Mendelian randomization analyses
Neil Murphy, Anika Knüppel, … Marc James Gunter·Annals of OncologyPeer-reviewed·Mar 10, 2020